company background image
TRU logo

TruScreen Group NZSE:TRU Stock Report

Last Price

NZ$0.023

Market Cap

NZ$12.7m

7D

-11.5%

1Y

0%

Updated

22 Dec, 2024

Data

Company Financials

TRU Stock Overview

Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. More details

TRU fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

TruScreen Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for TruScreen Group
Historical stock prices
Current Share PriceNZ$0.023
52 Week HighNZ$0.03
52 Week LowNZ$0.015
Beta-0.055
1 Month Change4.55%
3 Month Change9.52%
1 Year Change0%
3 Year Change-71.25%
5 Year Change-72.94%
Change since IPO-83.57%

Recent News & Updates

Recent updates

Here's Why We're Not Too Worried About TruScreen Group's (NZSE:TRU) Cash Burn Situation

Oct 20
Here's Why We're Not Too Worried About TruScreen Group's (NZSE:TRU) Cash Burn Situation

We Think TruScreen Group (NZSE:TRU) Can Afford To Drive Business Growth

Jun 07
We Think TruScreen Group (NZSE:TRU) Can Afford To Drive Business Growth

Shareholder Returns

TRUNZ Medical EquipmentNZ Market
7D-11.5%0.6%1.2%
1Y0%18.9%6.1%

Return vs Industry: TRU underperformed the NZ Medical Equipment industry which returned 18.9% over the past year.

Return vs Market: TRU underperformed the NZ Market which returned 6.1% over the past year.

Price Volatility

Is TRU's price volatile compared to industry and market?
TRU volatility
TRU Average Weekly Movement10.5%
Medical Equipment Industry Average Movement8.6%
Market Average Movement4.6%
10% most volatile stocks in NZ Market9.1%
10% least volatile stocks in NZ Market3.1%

Stable Share Price: TRU's share price has been volatile over the past 3 months compared to the NZ market.

Volatility Over Time: TRU's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

FoundedEmployeesCEOWebsite
2013n/aMartin Dillontruscreen.com

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020.

TruScreen Group Limited Fundamentals Summary

How do TruScreen Group's earnings and revenue compare to its market cap?
TRU fundamental statistics
Market capNZ$12.71m
Earnings (TTM)-NZ$1.83m
Revenue (TTM)NZ$2.68m

4.7x

P/S Ratio

-7.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TRU income statement (TTM)
RevenueNZ$2.68m
Cost of RevenueNZ$1.37m
Gross ProfitNZ$1.32m
Other ExpensesNZ$3.14m
Earnings-NZ$1.83m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0033
Gross Margin49.07%
Net Profit Margin-68.09%
Debt/Equity Ratio0%

How did TRU perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:31
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TruScreen Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stuart RobertsPitt Street Research Pty Ltd.